A longitudinal study of convalescent plasma ( CCP ) donors and correlation of ABO group, initial neutralizing antibodies ( nAb ), and body mass index ( BMI ) with nAb and anti‐nucleocapsid ( NP ) SARS‐CoV ‐2 antibody kinetics: Proposals for better quality of CCP collections-Reference-Cited by-同舟云学术

A longitudinal study of convalescent plasma ( CCP ) donors and correlation of ABO group, initial neutralizing antibodies ( nAb ), and body mass index ( BMI ) with nAb and anti‐nucleocapsid ( NP ) SARS‐CoV ‐2 antibody kinetics: Proposals for better quality of CCP collections

Published:2021-02-19 Issue:5 Volume:61 Page:1447-1460
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Wendel Silvano¹^ORCID,Fontão‐Wendel Rita¹,Fachini Roberta¹,Candelaria Gabriela¹,Scuracchio Patricia¹,Achkar Ruth¹,Brito Mayra¹,Reis Luiz Fernando²,Camargo Anamaria²,Amano Mariane²,Machado Rafael³^ORCID,Araujo Danielle³⁴^ORCID,Soares Camila³,Durigon Edison³

Affiliation:

1. Hospital Sírio‐Libanês Blood Bank São Paulo Brazil

2. Hospital Sírio‐Libanês São Paulo Brazil

3. Departamento de Microbiologia Instituto de Ciências Biomédicas, USP São Paulo Brazil

4. Hospital Israelita Albert Einstein São Paulo Brazil

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16323

Reference74 articles.

1. World Health Organization ‐ Naming the coronavirus disease (COVID‐19) and the virus that causes it. [cited 2020 Nov 5]. Available from:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.

2. World Health Organization (WHO) – Clinical management of COVID‐19. Interim guidance 27 May 2020 – WHO/2019‐nCoV/clinical/2020.5. [cited 2020 Nov 5]. Available from:https://www.who.int/publications-detail/clinical-management-of-covid-19.

3. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: A living systematic review;Chai KL;Cochrane Database Syst Rev,2020

4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

5. Guidance for the procurement of COVID‐19 convalescent plasma: Differences between high and low‐middle income countries;Bloch EM;Vox Sang,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between clinical symptoms during the COVID‐19 infection and SARS‐CoV‐2 immunoglobulin G titers in COVID‐19 convalescent whole‐blood donors in China;Transfusion;2024-04-25

2. Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster;Vaccines;2024-01-30

3. Bidirectionality between Cardiometabolic Diseases and COVID-19: Role of Humoral Immunity;Advances in Nutrition;2023-09

4. Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China;Frontiers in Immunology;2023-06-14

5. Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma.;Transfusion and Apheresis Science;2023-06